Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis
نویسندگان
چکیده
BackgroundClonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia undetermined significance (CCUS) are defined by somatic mutations in genes associated with myeloid neoplasms (MN) at a variant allele fraction (VAF) 0.02 or greater the absence presence cytopenia, respectively. CHIP/CCUS is highly prevalent adults, defining predictors MN risk would aid clinical management research.MethodsWe analyzed sequenced exomes healthy U.K. Biobank participants (N=438,890) separate derivation validation cohorts. Genetic mutations, laboratory values, outcomes were used conditional probability–based recursive partitioning Cox regression to determine incident MN. Combined statistical weights define score (CHRS). Independent patient cohorts test prognostic capability CHRS setting.ResultsRecursive distinguished patients 10-year probabilities ranging from 0.0077 0.85. Multivariable analysis validated variables as Key features, including single DNMT3A high-risk two more VAF 0.2 more, 65 years age older, having CCUS versus CHIP, red blood cell indices, influenced variable direction. was low-risk (n=10,018 [88.4%]), intermediate-risk (n=1196 [10.5%]), (n=123 [1.1%]) groups. In cohorts, most events occurred CHIP/CCUS.ConclusionsThe provides simple framework for CHIP/CCUS, distinguishing minority majority which has minimal progression (Funded National Institutes Health, Harold Amos Medical Faculty Development Program, others.)
منابع مشابه
Pre-leukemic clonal hematopoiesis and the risk of therapy-related myeloid neoplasms: a case-control study
BACKGROUND Therapy-related myeloid neoplasms are secondary malignancies that are often fatal, but their risk factors are not well understood. Evidence suggests that individuals with clonal haemopoiesis have increased risk of developing haematological malignancies. We aimed to identify whether patients with cancer who have clonal haemopoiesis are at an increased risk of developing therapy-relate...
متن کاملpreoperative evaluation of risk of ovarian malignancy algorithm index in prediction of malignancy of adnexal masses
results: the only significant difference was the older age of the malignant group vs. benign group (p = 0.001) regarding demographic findings. as concerns the clinical symptoms, presence of abdominal discomfort in pre-diagnosis period was the only significant parameter in malignant group (p = 0.001). additionally, data analysis of patients as a total group showed that specificity (96.4%), posit...
متن کاملPhiladelphia-negative clonal hematopoiesis is a significant feature of dasatinib therapy for chronic myeloid leukemia
sia” in the paper by Ciurea et al1 should be replaced by “neoplastic accumulation of megakaryocytes.” The process is an accumulation of neoplastic, not hyperplastic, megakaryocytes as a result of an increased clonal production of megakaryocytes and a decrease in apoptotic signaling in the neoplastic megakaryocytes, as they have skillfully confirmed. The correct use of the term hyperplasia in no...
متن کاملChipping in on clonal hematopoiesis
Myeloid neoplasms are clonal diseases of hematopoietic stem or progenitor cells that result from molecular alterations that perturb cellular self-renewal, proliferation, and differentiation. As classified by the World Health Organization, myeloid neoplasms include myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS), MPN/MDS overlap, and acute myeloid leukemia (AML), which can oc...
متن کاملClonal Hematopoiesis in Aplastic Anemia
WENTY-FIVE YEARS AGO, William Dameshek, T the founder of this journal and one of the most creative minds in American hematology, raised a provocative question: what do aplastic anemia (AA), paroxysmal nocturnal hemoglobinuria (PNH), and acute leukemia have in common?’ His question was prompted by three observations: (1) the frequency of development of PNH in his own patients with AA, (2) the ov...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: NEJM evidence
سال: 2023
ISSN: ['2766-5526']
DOI: https://doi.org/10.1056/evidoa2200310